Dr Fiona Godlee, editor in chief of the British Medical Journal, says the system for drug regulation is "clearly flawed", while Barry Clinch, Roche's global development leader for Tamiflu, says he disagrees with the findings of a report questioning the efficacy of Tamiflu.